Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands
Erasmus Centre for Health Economics, Erasmus University Rotterdam, Rotterdam, The Netherlands.
BMJ Open. 2023 Aug 24;13(8):e066213. doi: 10.1136/bmjopen-2022-066213.
The burden of non-communicable diseases (NCDs) has increased substantially in low- and middle-income countries (LMICs), and adapting health service delivery models to address this remains a challenge. Many patients with NCD seek private care at different points in their encounters with the health system, but the determinants and outcomes of these choices are insufficiently understood. The proposed systematic review will help inform the governance of mixed health systems towards achieving the goal of universal health coverage. This protocol details our intended methodological and analytical approaches, based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).
Following the PRISMA approach, this systematic review will develop a descriptive synthesis of the determinants and outcomes of private healthcare utilisation for NCDs in LMICs. The databases Embase, Medline, Web of Science Core Collection, EconLit, Global Index Medicus and Google Scholar will be searched for relevant studies published in English between period 1 January 2010 and 30 June 2022 with additional searching of reference lists. The study selection process will involve a title-abstract and full-text review, guided by clearly defined inclusion and exclusion criteria. A quality and risk of bias assessment will be done for each study using the Mixed Methods Appraisal Tool.
Ethical approval is not required because this review is based on data collected from publicly available materials. The results will be published in a peer-reviewed journal and presented at related scientific events.
CRD42022340059.
在中低收入国家(LMICs),非传染性疾病(NCDs)的负担大大增加,适应卫生服务提供模式以解决这一问题仍然是一个挑战。许多 NCD 患者在与卫生系统接触的不同阶段寻求私人护理,但这些选择的决定因素和结果了解不足。拟议的系统评价将有助于为混合卫生系统的治理提供信息,以实现全民健康覆盖的目标。本方案详细说明了我们基于系统评价和荟萃分析的首选报告项目(PRISMA)的预期方法学和分析方法。
根据 PRISMA 方法,本系统评价将对 LMICs 中 NCD 私人医疗保健利用的决定因素和结果进行描述性综合。将在 2010 年 1 月 1 日至 2022 年 6 月 30 日期间以英文发表的相关研究在 Embase、Medline、Web of Science 核心合集、EconLit、全球索引医学和 Google Scholar 数据库中进行搜索,并通过附加搜索参考列表进行搜索。研究选择过程将根据明确界定的纳入和排除标准进行标题-摘要和全文审查。使用混合方法评估工具对每项研究进行质量和偏倚风险评估。
由于本审查基于从公开可用材料中收集的数据,因此不需要伦理批准。结果将发表在同行评议的期刊上,并在相关科学活动中展示。
PROSPERO 注册号:CRD42022340059。